5 & 6 June 2024
Palexpo, Geneva
Menu Close

BD invests €4 million into a new R&D facility and €30 million in a manufacturing facility

BD (Becton, Dickinson and Company) is a leading global medical technology company that focuses on advancing healthcare through improved medical discovery, diagnostics, and care delivery. They have announced the opening of a new €4 million research & development (R&D) facility in Blackrock, Ireland. Plus, it will be investing an additional €30 million into expanding its manufacturing facility in Enniscorthy.

The new BD R&D facility will focus on the commercialisation of BD Evolve™ On-Body Injector, its first on-body injectable device. This device meets the growing demand for injectable drugs in the pharmaceutical industry. Additionally, the R&D facility will serve as the regional base for BD’s Sales, Technical Service, and Corporate Functional Support Teams.

The €30 million investment into the Enniscorthy manufacturing facility will house operations related to manufacturing a new medical technology from BD’s Peripheral Intervention business unit.

Follow us:

Share this article:


Sign Up to our newsletter

What are they signing up yo with the newsletter?

*Please note that all newsletters are in English, while PCD and PLD also have a French version available.

At Easyfairs, we take your privacy seriously and will only use the information we collect or receive about you in accordance with our privacy policy. If you change your mind you can unsubscribe at any time.